「with」の検索結果
108件：41～45件目を表示
-
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
開催地：Salt Lake City, Utah, United States of America Establishment of in vitro drug evaluation model with retinal ganglion cells from Leber’s hereditary optic neuropathy (LHON) patient-derived iPSC R.I...
https://www.senju.co.jp/rd/society/ -
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
愛媛大学医学部眼科学教室 2)千寿製薬株式会社 3)日野病院 あたらしい眼科42(12)：1566～1576 Efficacy and Safety of SJP-0132 in Patients with Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuk...
https://www.senju.co.jp/rd/thesis/ -
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
s T, et al. RNA-Seq-based transcriptome analysis of corneal endothelial cells derived from patients with Fuchs endothelial corneal dystrophy. Sci Rep. 2023;13(1):8647. #6: Krachmer JH, Purcell JJ Jr,...
https://www.senju.co.jp/rd/policy/ -
nju is committed to obtaining marketing approval for the DED treatment SJP-0132 to provide patients with new options for alleviating the signs and symptoms of this disease. Mochida is dedicated to lev...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf -
Medical devices and healthcare | Business Activities | About Senju | SENJU Pharmaceutical
he world. Senju Pharmaceutical has taken on the challenge of forming the Vision Care Platform along with the pharmaceutical business to support total care in the ophthalmic area (care for presymptomat...
https://www.senju.co.jp/english/about/business/device.html